Schedule 13G ownership disclosure

THERAVANCE BIOPHARMA INC

Security class unavailable · CUSIP: G8807B106

Event date: 2020-06-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-176545
Form type
SC 13G/A
Filer
Link Fund Solutions Ltd
CIK
CIK 1792424
Filed
Jun 23, 2020
Reporting period
Jun 04, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub